Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-03-17
1996-01-02
Dees, Jose G.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
546264, 560 35, 562440, C07D21330, C07D21342, C07D21353, C07D21354
Patent
active
054809983
ABSTRACT:
An oxime derivative (I): ##STR1## that D ring and B bonding to D ring are (i)-(iv), wherein R.sup.1 is hydrogen, lower alkyl; R.sup.2 is hydrogen, alkyl, phenyl, cycloalkyl, monocyclic ring containing nitrogen, lower alkyl substituted by benzene ring or cycloalkyl, lower alkyl substituted by monocyclic ring containing nitrogen; R.sup.3 is alkyl, phenyl, cycloalkyl, monocyclic ring containing nitrogen, lower alkyl substituted by benzene ring or cycloalkyl, lower alkyl substituted by monocyclic ring containing nitrogen; e is 3-5, f is 1-3, p is 1-4, q is 1-2, r is 1-3; the position of the bond to D ring in (iii) and (iv) is a or b, and the ring in R.sup.2 and R.sup.3 may be substituted by lower alkyl, alkoxy, halogen, nitro, trihalomethyl; and salts thereof, possess an agonistic activity on PGl2 receptor, and therefore are useful for prevention and/or treatment of thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer and hypertension.
REFERENCES:
patent: 4352804 (1982-10-01), van Zorge
patent: 4954523 (1990-09-01), Yamagishi et al.
patent: 4971985 (1990-11-01), Otsuka et al.
Chemical Abstracts, vol. 118, 1993, Columbus, Ohio, U.S.; Abstract No. 19130b.
Nature, vol. 263, pp. 663-665, Oct. 21, 1976, "An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation", Moncada et al.
Prostaglandins, vol. 12, No. 5, pp. 685-713, Nov. 1976, "Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) . . . endoperoxides", Gryglewski et al.
Prostaglandins, vol. 12, No. 6, pp. 915-928, Dec. 1976, "The chemical structure of prostaglandin X (prostacyclin)", Johnson et al.
Prostaglandins, vol. 13, No. 3, pp. 377-388, Mar. 1977, "Modulation of human platelet adenylate cyclase by prostacyclin (PGX)", Gorman et al.
Chemical & Engineering News, pp. 17-19, Dec. 20, 1976, "New compound shakes up prostaglandin ideas".
British Journal of Pharmacology, vol. 76, pp. 423-438, 1982, "Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and . . . trachea", Jones et al.
British Journal of Pharmacology, vol. 84, pp. 595-607, 1985, "Competitive antagonism at thromboxane receptors in human platelets", Armstrong et al.
British Journal of Pharmacology, vol. 102, pp. 251-259, 1991, "Octimibate, a potent non-prostanoid inhibitor, acts via the prostacyclin receptor" Merritt et al.
British Journal of Pharmacology, vol. 86, p. 643P, 1986, "Novel prostaglandin endoperoxide analogues which block thromboxane receptors and mimic prostacyclin" Armstrong et al.
Moffett et al., J. Het. Chem., 16, pp. 1459-1467 (1979).
Hamanaka Nobuyuki
Takahashi Kanji
Tokumoto Hidekado
Dees Jos,e G.
Frazier Barbara S.
Ono Pharmaceutical Co. Ltd.
LandOfFree
Oxime derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxime derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxime derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-236252